Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DR26F3DX5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,989
Award facts
- Contract value 100% obligated
- $14,988.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Cosentyx (secukinumab) 300mg dose in 2 pen/ml formulation. This $14,988.54 firm fixed-price delivery order, with an ultimate completion date of November 21, 2025, represents a competitively awarded non-set-aside contract executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's headquarters location. Cosentyx is a biologic immunosuppressant medication used to treat various autoimmune conditions, supporting the Defense Health System's pharmaceutical supply needs for military personnel and beneficiaries.
This delivery order is issued under AmerisourceBergen's $999.999 billion DLA IDC (SPE2DX) running through December 2026, which serves as a global pharmaceutical support vehicle enabling the company to supply an extensive range of medications and medical supplies to military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen demonstrates substantial capability in fulfilling federal requirements through open competition, with a demonstrated portfolio spanning specialty medications, vaccines, medical devices, and generic pharmaceuticals across multiple therapeutic domains serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F3DX5?
SPE2DR26F3DX5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26F3DX5 worth?
The government has obligated $14,989 on SPE2DR26F3DX5.
Is contract SPE2DR26F3DX5 an order under another contract?
Yes. SPE2DR26F3DX5 is a delivery order under SPE2DR25D3017, an indefinite delivery contract.
Was contract SPE2DR26F3DX5 competed?
The extent of competition for SPE2DR26F3DX5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award